Ergebnisse

Alle Filter löschen

Hersteller:DCChemicals Filter entfernen

Oncology

Forschungsbereich der Onkologie

Molekulare Mechanismen von Krebserkrankungen zu entdecken und passende Wirkstoffe zu identifizieren stellen wichtige Teilbereiche in der Krebsforschung dar.

Die Tumordiversität ist sehr hoch. Dementsprechend gehört die Krebsforschung zu einem der vielfältigsten Forschungsbereiche und umfasst viele wissenschaftliche Ansätze.

Wir bieten Ihnen deshalb eine konkurrenzlose Produktvielfalt für die onkologische Forschung und Entwicklung im akademischen sowie pharmazeutischen Bereich an.

Klicke auf die Organe und erfahre mehr über verschiedene Krebsarten

Allgemeine Informationen

Onkologen befassen sich mit der Diagnose, Therapie und Nachsorge von Krebs.
Krebs ist eine Klasse von Krankheiten, bei der sich entartete Zellen unkontrolliert teilen und in andere Gewebe eindringen können. Krebszellen können sich über das Blut- und Lymphsystem auf andere Teile des Körpers ausbreiten. Normalerweise wird die Zellproliferation durch viele Mechanismen streng kontrolliert. Darüber hinaus ist das Immunsystem in der Lage, Krebszellen zu erkennen und zu zerstören.
Funktionieren diese Mechanismen nicht richtig oder das Immunsystem kann die Zellen nicht effektiv zerstören, kann es zu einem malignen Tumor kommen. Eine bösartige Neoplasie ist theoretisch überall möglich, es gibt jedoch Krebsarten, die häufiger vorkommen als andere. Bei Männern ist die Prostata und bei Frauen die Brustdrüse die häufigste Tumorlokalisation.

Relevante Produkte für die onkologische Forschung

Name	Typ	Specific against	Appl.	ArtNr.	Menge	Preis
Arginase inhibitor 1	Inhibitors	Other		DCC-DC50092-100mg DCChemicals	100 mg	Anmelden Vergleichen	Arginase inhibitor 1
Arginase inhibitor 1	Inhibitors	Other		DCC-DC50092-250mg DCChemicals	250 mg	Anmelden Vergleichen	Arginase inhibitor 1
Arginase inhibitor 1	Inhibitors	Other		DCC-DC50092-1g DCChemicals	1 g	Anmelden Vergleichen	Arginase inhibitor 1
Glucocorticoid receptor modulator-1	Chemicals	Other	A novel Glucocorticoid receptor modulator.	DCC-DC57060-5mg DCChemicals	5 mg	Anmelden Vergleichen	Glucocorticoid receptor modulator-1
L-Methionine sulfoxide	Chemicals	Other	L-Methionine sulfoxide (H-Met(O)-OH), a metabolite of Methionine, induces M1/classical macrophage polarization, and modulates oxidative stress and purinergic signaling parameters.	DCC-DC29170-100mg DCChemicals	100 mg	Anmelden Vergleichen	L-Methionine sulfoxide
L-Methionine sulfoxide	Chemicals	Other	L-Methionine sulfoxide (H-Met(O)-OH), a metabolite of Methionine, induces M1/classical macrophage polarization, and modulates oxidative stress and purinergic signaling parameters.	DCC-DC29170-250mg DCChemicals	250 mg	Anmelden Vergleichen	L-Methionine sulfoxide
L-Methionine sulfoxide	Chemicals	Other	L-Methionine sulfoxide (H-Met(O)-OH), a metabolite of Methionine, induces M1/classical macrophage polarization, and modulates oxidative stress and purinergic signaling parameters.	DCC-DC29170-1g DCChemicals	1 g	Anmelden Vergleichen	L-Methionine sulfoxide
CD73 inhibitor AB-680	Inhibitors	Other		DCC-DC21981-100mg DCChemicals	100 mg	Anmelden Vergleichen	CD73 inhibitor AB-680
CD73 inhibitor AB-680	Inhibitors	Other		DCC-DC21981-250mg DCChemicals	250 mg	Anmelden Vergleichen	CD73 inhibitor AB-680
CD73 inhibitor AB-680	Inhibitors	Other		DCC-DC21981-1g DCChemicals	1 g	Anmelden Vergleichen	CD73 inhibitor AB-680
TTK21(CBP-p300 activator TTK21)	Chemicals	Other		DCC-DC23396-1g DCChemicals	1 g	Anmelden Vergleichen	TTK21(CBP-p300 activator TTK21)
Mps1-IN-3	Inhibitors	Other		DCC-DC23974-1g DCChemicals	1 g	Anmelden Vergleichen	Mps1-IN-3
MMP-1/MMP-9 Fluorogenic Substrate	Chemicals	Other	other	DCC-DC11348-250mg DCChemicals	250 mg	Anmelden Vergleichen	MMP-1/MMP-9 Fluorogenic Substrate
MMP-1/MMP-9 Fluorogenic Substrate	Chemicals	Other	other	DCC-DC11348-100mg DCChemicals	100 mg	Anmelden Vergleichen	MMP-1/MMP-9 Fluorogenic Substrate
Lorcaserin	Chemicals	Other	IS	DCC-DC1011-50mg DCChemicals	50 mg	Anmelden Vergleichen	Lorcaserin
MSA-2	Chemicals	Other		DCC-DC39031-1g DCChemicals	1 g	Anmelden Vergleichen	MSA-2
GSK046 (iBET-BD2)	Inhibitors	Other		DCC-DC39702-250mg DCChemicals	250 mg	Anmelden Vergleichen	GSK046 (iBET-BD2)
GSK046 (iBET-BD2)	Inhibitors	Other		DCC-DC39702-1g DCChemicals	1 g	Anmelden Vergleichen	GSK046 (iBET-BD2)
SIRT6 activator 12q	Chemicals	Other	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model	DCC-DC42568-100mg DCChemicals	100 mg	Anmelden Vergleichen	SIRT6 activator 12q
SIRT6 activator 12q	Chemicals	Other	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model	DCC-DC42568-250mg DCChemicals	250 mg	Anmelden Vergleichen	SIRT6 activator 12q
SIRT6 activator 12q	Chemicals	Other	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model	DCC-DC42568-1g DCChemicals	1 g	Anmelden Vergleichen	SIRT6 activator 12q
MSA-2	Chemicals	Other		DCC-DC39031-250mg DCChemicals	250 mg	Anmelden Vergleichen	MSA-2
PD-1/PD-L1-IN 3	Inhibitors	Other		DCC-DC44154-25mg DCChemicals	25 mg	Anmelden Vergleichen	PD-1/PD-L1-IN 3
PD-1/PD-L1-IN 3	Inhibitors	Other		DCC-DC44154-10mg DCChemicals	10 mg	Anmelden Vergleichen	PD-1/PD-L1-IN 3
Complement factor D-IN-2	Chemicals	Other	Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Complement factor D-IN-2 targets factor D and inhibits the complement cascade at an early and essential point in the alternative complement pathway. Complement factor D-IN-2 can be used for the research of autoimmune diseases.	DCC-DC44151-1g DCChemicals	1 g	Anmelden Vergleichen	Complement factor D-IN-2

Name Preis

Arginase inhibitor 1

Anmelden

Arginase inhibitor 1

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC50092-100mg
Menge	100 mg
Lieferbar

Arginase inhibitor 1

Anmelden

Arginase inhibitor 1

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC50092-250mg
Menge	250 mg
Lieferbar

Arginase inhibitor 1

Anmelden

Arginase inhibitor 1

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC50092-1g
Menge	1 g
Lieferbar

Glucocorticoid receptor modulator-1

Anmelden

Glucocorticoid receptor modulator-1

Typ	Chemicals
Clone
Specific against	Other
Appl.	A novel Glucocorticoid receptor modulator.
Host
ArtNr.	DCC-DC57060-5mg
Menge	5 mg
Lieferbar

L-Methionine sulfoxide

Anmelden

L-Methionine sulfoxide

Typ	Chemicals
Clone
Specific against	Other
Appl.	L-Methionine sulfoxide (H-Met(O)-OH), a metabolite of Methionine, induces M1/classical macrophage polarization, and modulates oxidative stress and purinergic signaling parameters.
Host
ArtNr.	DCC-DC29170-100mg
Menge	100 mg
Lieferbar

L-Methionine sulfoxide

Anmelden

L-Methionine sulfoxide

Typ	Chemicals
Clone
Specific against	Other
Appl.	L-Methionine sulfoxide (H-Met(O)-OH), a metabolite of Methionine, induces M1/classical macrophage polarization, and modulates oxidative stress and purinergic signaling parameters.
Host
ArtNr.	DCC-DC29170-250mg
Menge	250 mg
Lieferbar

L-Methionine sulfoxide

Anmelden

L-Methionine sulfoxide

Typ	Chemicals
Clone
Specific against	Other
Appl.	L-Methionine sulfoxide (H-Met(O)-OH), a metabolite of Methionine, induces M1/classical macrophage polarization, and modulates oxidative stress and purinergic signaling parameters.
Host
ArtNr.	DCC-DC29170-1g
Menge	1 g
Lieferbar

CD73 inhibitor AB-680

Anmelden

CD73 inhibitor AB-680

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC21981-100mg
Menge	100 mg
Lieferbar

CD73 inhibitor AB-680

Anmelden

CD73 inhibitor AB-680

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC21981-250mg
Menge	250 mg
Lieferbar

CD73 inhibitor AB-680

Anmelden

CD73 inhibitor AB-680

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC21981-1g
Menge	1 g
Lieferbar

TTK21(CBP-p300 activator TTK21)

Anmelden

TTK21(CBP-p300 activator TTK21)

Typ	Chemicals
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC23396-1g
Menge	1 g
Lieferbar

Mps1-IN-3

Anmelden

Mps1-IN-3

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC23974-1g
Menge	1 g
Lieferbar

MMP-1/MMP-9 Fluorogenic Substrate

Anmelden

MMP-1/MMP-9 Fluorogenic Substrate

Typ	Chemicals
Clone
Specific against	Other
Appl.	other
Host
ArtNr.	DCC-DC11348-250mg
Menge	250 mg
Lieferbar

MMP-1/MMP-9 Fluorogenic Substrate

Anmelden

MMP-1/MMP-9 Fluorogenic Substrate

Typ	Chemicals
Clone
Specific against	Other
Appl.	other
Host
ArtNr.	DCC-DC11348-100mg
Menge	100 mg
Lieferbar

Lorcaserin

Anmelden

Lorcaserin

Typ	Chemicals
Clone
Specific against	Other
Appl.	IS
Host
ArtNr.	DCC-DC1011-50mg
Menge	50 mg
Lieferbar

MSA-2

Anmelden

MSA-2

Typ	Chemicals
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC39031-1g
Menge	1 g
Lieferbar

GSK046 (iBET-BD2)

Anmelden

GSK046 (iBET-BD2)

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC39702-250mg
Menge	250 mg
Lieferbar

GSK046 (iBET-BD2)

Anmelden

GSK046 (iBET-BD2)

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC39702-1g
Menge	1 g
Lieferbar

SIRT6 activator 12q

Anmelden

SIRT6 activator 12q

Typ	Chemicals
Clone
Specific against	Other
Appl.	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model
Host
ArtNr.	DCC-DC42568-100mg
Menge	100 mg
Lieferbar

SIRT6 activator 12q

Anmelden

SIRT6 activator 12q

Typ	Chemicals
Clone
Specific against	Other
Appl.	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model
Host
ArtNr.	DCC-DC42568-250mg
Menge	250 mg
Lieferbar

SIRT6 activator 12q

Anmelden

SIRT6 activator 12q

Typ	Chemicals
Clone
Specific against	Other
Appl.	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model
Host
ArtNr.	DCC-DC42568-1g
Menge	1 g
Lieferbar

MSA-2

Anmelden

MSA-2

Typ	Chemicals
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC39031-250mg
Menge	250 mg
Lieferbar

PD-1/PD-L1-IN 3

Anmelden

PD-1/PD-L1-IN 3

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC44154-25mg
Menge	25 mg
Lieferbar

PD-1/PD-L1-IN 3

Anmelden

PD-1/PD-L1-IN 3

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC44154-10mg
Menge	10 mg
Lieferbar

Complement factor D-IN-2

Anmelden

Complement factor D-IN-2

Typ	Chemicals
Clone
Specific against	Other
Appl.	Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Complement factor D-IN-2 targets factor D and inhibits the complement cascade at an early and essential point in the alternative complement pathway. Complement factor D-IN-2 can be used for the research of autoimmune diseases.
Host
ArtNr.	DCC-DC44151-1g
Menge	1 g
Lieferbar

Oncology

Forschungsbereich der Onkologie

Klicke auf die Organe und erfahre mehr über verschiedene Krebsarten

Allgemeine Informationen

Relevante Produkte für die onkologische Forschung

Kontakt

Über Hölzel

Service

Infothek

ANMELDEN & VORTEILE SICHERN

Ergebnisse filtern

Oncology

Forschungsbereich der Onkologie

Klicke auf die Organe und erfahre mehr über verschiedene Krebsarten

Allgemeine Informationen

Relevante Produkte für die onkologische Forschung

Kontakt

Über Hölzel

Service

Infothek